MAAT-YS Program for Young Adult Cancer Survivors

(MAAT-YACCS Trial)

This trial tests a telehealth program called MAAT-YS, designed to assist young adults who survived childhood cancer and now face memory and attention issues due to their cancer or its treatment. Participants will engage in eight weekly 45-minute sessions, using a workbook and completing homework to enhance cognitive function and quality of life. The study seeks cancer survivors aged 18-39 who completed treatment at least a year ago, are cancer-free, and experience memory or other cognitive problems. As an unphased trial, this study provides a unique opportunity to contribute to research that could improve cognitive support for cancer survivors.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research shows that Memory and Attention Adaptation Training (MAAT) helps cancer survivors manage memory and attention problems. While specific safety data for the customized MAAT-YS for young adult cancer survivors is not available, similar therapies have been well-received.

In past studies, MAAT has helped survivors address memory and attention issues. These therapies usually avoid physical side effects because they rely on psychological techniques instead of medication. Participants often engage in activities like using workbooks and completing assignments, which are generally safe.

Researchers are excited about the MAAT-YS program because it offers a fresh approach to supporting young adult cancer survivors. Unlike traditional treatments that often focus on the physical aspects of recovery, MAAT-YS emphasizes cognitive-behavioral therapy to address emotional and psychological well-being. This program is tailored specifically to the unique challenges faced by young adults, aiming to improve their quality of life and mental resilience after cancer treatment. By targeting psychological health directly, MAAT-YS has the potential to complement existing care, leading to a more holistic recovery process.

Studies have shown that cognitive behavioral therapy (CBT) can improve mental health and quality of life in cancer patients, particularly younger ones. Research indicates that CBT leads to moderate improvements, noticeably enhancing how patients feel and function. Early findings suggest that young adult cancer survivors often encounter cognitive and mental health challenges during and after treatment. In this trial, participants will receive MAAT-YS, a specialized CBT program designed to address these specific issues.¹³⁶⁷⁸